Thromboangiitis obliterans
MONDO:0008889A rare inflammatory non-necrotizing vascular disease affecting the small- and medium-sized arteries and veins of the upper and lower extremities characterized by endarteritis and vaso-occlusion due to occlusive thrombus development. The development and progression of the disease is consistently associated with exposure to tobacco.
Also known as: Buerger's Disease, Buerger's disease, thromboangiitis obliterans, thromboangiitis obliterans [Buerger's disease], BUERGER disease, TAO, inflammatory occlusive peripheral vascular disease, occlusive peripheral vascular disease
8 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New hope for rare disease patients with Non-Healing wounds
Disease control APPROVED_FOR_MARKETINGThis program offers selexipag (Uptravi) to a single patient with Buerger's disease who has a wound that won't heal. The goal is to see if the drug can help control the disease and improve wound healing. This is not a cure, and the patient may need ongoing treatment.
Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New registry monitors VBX stent graft in Real-World use
Knowledge-focused OngoingThis study is a registry that collects safety and performance data on the GORE® VIABAHN® VBX Stent Graft when used in peripheral vessels. It involves 280 adults who need this device to treat peripheral vascular disease. The goal is to see how well the stent graft works and if the…
Sponsor: W.L.Gore & Associates • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC